Keppra ( Levetiracetam Vial) 500 mg/5ml

Keppra (Levetiracetam) 500 mg/5ml vials provide anticonvulsant therapy for seizure management. This Switzerland-made solution stores below 25°C and is used in epilepsy care. Keppra vials offer reliable antiepileptic support with convenient dosing. Suitable for patients requiring liquid anticonvulsant formulations.

Strength

500 mg/5ml

Pack Size

10s

Storage

Below 25°C

Manufacturer / TM Owner

UCB-PHARMA AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Levetiracetam is an antiepileptic medication primarily used to control seizures in epilepsy. It helps reduce the frequency of partial-onset seizures in adults and children. Keppra vials are administered to patients who cannot take tablets or require liquid formulations. This medication works by calming overactive brain signals that trigger seizures. It is also used for certain types of seizure disorders as prescribed by healthcare providers.

Side Effects

Keppra vials may cause mild drowsiness or dizziness in some users. Patients often report feeling calmer or more focused after starting treatment. Headaches or fatigue are common during the initial adjustment period. Some individuals experience changes in mood or behavior, which should be monitored. These effects typically lessen as the body adapts to the medication.

Precautions & Warnings

Store Keppra vials below 25°C in a dry place away from direct sunlight. Keep the medication out of reach of children and pets. Do not use if the solution appears discolored or contains particles. Always check the expiration date before administration. Consult a healthcare provider if you experience persistent side effects or unusual symptoms.

Avoid Interactions

Alcohol may increase drowsiness when combined with Keppra. Certain medications, such as other anticonvulsants or sedatives, can interact with Levetiracetam. Always inform your doctor about all prescription and over-the-counter drugs you are taking. Some interactions may reduce effectiveness or increase side effects. Caution is advised when combining with medications that affect the central nervous system.

Frequently Asked Questions

Keppra (Levetiracetam) is used to control seizures in epilepsy, including partial-onset seizures.

Keppra vials are typically administered orally or via feeding tubes as directed by a healthcare professional.

Yes, drowsiness or dizziness is a common effect, especially when starting treatment.

Keppra is prescribed for seizure control in both adults and children, depending on medical guidance.

Store below 25°C in a dry place, away from light and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.